130 related articles for article (PubMed ID: 22700553)
1. Discovery of a compound that acts as a bacterial PyrG (CTP synthase) inhibitor.
Yoshida T; Nasu H; Namba E; Ubukata O; Yamashita M
J Med Microbiol; 2012 Sep; 61(Pt 9):1280-1285. PubMed ID: 22700553
[TBL] [Abstract][Full Text] [Related]
2. Discovery of a compound which acts as a bacterial UMP kinase PyrH inhibitor.
Yoshida T; Nasu H; Namba E; Ubukata O; Yamashita M
FEMS Microbiol Lett; 2012 May; 330(2):121-6. PubMed ID: 22428584
[TBL] [Abstract][Full Text] [Related]
3. Antimicrobial activity of the new macrolide flurithromycin against Haemophilus influenzae, Streptococcus pneumoniae, Streptococcus pyogenes, Branhamella catarrhalis and Staphylococcus aureus.
Nord CE; Lindmark A; Persson I
J Chemother; 1989 Jul; 1(4 Suppl):203-4. PubMed ID: 16312369
[No Abstract] [Full Text] [Related]
4. Expression of the pyrG gene determines the pool sizes of CTP and dCTP in Lactococcus lactis.
Jørgensen CM; Hammer K; Jensen PR; Martinussen J
Eur J Biochem; 2004 Jun; 271(12):2438-45. PubMed ID: 15182359
[TBL] [Abstract][Full Text] [Related]
5. A Phenotypic Based Target Screening Approach Delivers New Antitubercular CTP Synthetase Inhibitors.
Esposito M; Szadocka S; Degiacomi G; Orena BS; Mori G; Piano V; Boldrin F; Zemanová J; Huszár S; Barros D; Ekins S; Lelièvre J; Manganelli R; Mattevi A; Pasca MR; Riccardi G; Ballell L; Mikušová K; Chiarelli LR
ACS Infect Dis; 2017 Jun; 3(6):428-437. PubMed ID: 28475832
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics/Pharmacodynamics of Peptide Deformylase Inhibitor GSK1322322 against Streptococcus pneumoniae, Haemophilus influenzae, and Staphylococcus aureus in Rodent Models of Infection.
Hoover J; Lewandowski T; Straub RJ; Novick SJ; DeMarsh P; Aubart K; Rittenhouse S; Zalacain M
Antimicrob Agents Chemother; 2016 Jan; 60(1):180-9. PubMed ID: 26482300
[TBL] [Abstract][Full Text] [Related]
7. Characterization of temperature-sensitive cytidine triphosphate synthase mutations in bacteria by high-performance liquid chromatography.
Bailey AJ; Dutta PK; Shanley MS; O'Donovan GA
J Chromatogr; 1990 Jul; 512():403-7. PubMed ID: 2229235
[TBL] [Abstract][Full Text] [Related]
8. Discovery of piperazic acid peptide deformylase inhibitors with in vivo activity for respiratory tract and skin infections.
Spletstoser JT; Dreabit J; Knox AN; Benowitz A; Campobasso N; Ward P; Cui G; Lewandowski T; McCloskey L; Aubart KM
Bioorg Med Chem Lett; 2019 Aug; 29(16):2410-2414. PubMed ID: 31160176
[TBL] [Abstract][Full Text] [Related]
9. CTP limitation increases expression of CTP synthase in Lactococcus lactis.
Jørgensen CM; Hammer K; Martinussen J
J Bacteriol; 2003 Nov; 185(22):6562-74. PubMed ID: 14594829
[TBL] [Abstract][Full Text] [Related]
10. Comparative activity of telithromycin against typical community-acquired respiratory pathogens.
Buxbaum A; Forsthuber S; Graninger W; Georgopoulos A
J Antimicrob Chemother; 2003 Sep; 52(3):371-4. PubMed ID: 12888585
[TBL] [Abstract][Full Text] [Related]
11. Crizotinib Shows Antibacterial Activity against Gram-Positive Bacteria by Reducing ATP Production and Targeting the CTP Synthase PyrG.
Zheng YD; Zhong T; Wu H; Li N; Fang Z; Cao L; Yin XF; He QY; Ge R; Sun X
Microbiol Spectr; 2022 Jun; 10(3):e0088422. PubMed ID: 35674439
[TBL] 
